Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries
The approval is supported by results from the Phase 3 SWOG 1826 trial
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.
We are contributing to the Indian pharmaceutical and laboratory sectors through advanced analytical instrumentation, automated liquid handling, and molecular biology solutions. Our technologies empower research and Quality Control (QC) by ensuring regulatory compliance and streamlined workflows…
Pfizer says the broader dataset across all 25 serotypes strengthens confidence that the program can meet non-inferiority thresholds in its upcoming Phase 3 pediatric trials
The therapy is suited for patients with severe valve leakage who face elevated surgical risk due to advanced age, frailty, or multiple medical complications
The new facility at Byatarayanapura introduces Karnataka’s first Elekta Unity MR-Linac technology
Subscribe To Our Newsletter & Stay Updated
